Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3104 ARTÍCULOS , VIENDO DEL 1 AL 15

Engineered Probiotic and Prebiotic Nutraceutical Supplementations in Combating Non-communicable Disorders: A Review

Kerry RG, Das G, Golla U, Del Pilar Rodriguez-Torres M, Shin HS, Patra JK.

Curr Pharm Biotechnol. 2022;23(1):72-97. doi: 10.2174/1389201021666201013153142.

Persons with Co-Existing Neurological Disorders: Risk Analysis, Considerations and Management in COVID-19 Pandemic

Sharma S, Batra S, Gupta S, Sharma VK, Rahman MH, Kamal MA.

CNS Neurol Disord Drug Targets. 2022;21(3):228-234. doi: 10.2174/1871527320666210308113457.

Neural Basis of Dental Pulp Stem Cells and its Potential Application in Parkinson's Disease

Sharma Y, Shobha K, Sundeep M, Pinnelli VB, Parveen S, Dhanushkodi A.

CNS Neurol Disord Drug Targets. 2022;21(1):62-76. doi: 10.2174/1871527320666210311122921.

Antioxidant Activity of 1,2,4-Triazole and its Derivatives: A Mini-Review

Pachuta-Stec A.

Mini Rev Med Chem. 2022;22(7):1081-1094. doi: 10.2174/1389557521666210401091802.

Evidence to Support the Use of S-Adenosylmethionine for Treatment of Post-Concussive Sequelae in the Military

Schieffler DA, Matta SE.

Mil Med. 2022 Aug 25;187(9-10):e1182-e1192. doi: 10.1093/milmed/usab130.

The intestinal luminal sources of α-synuclein: a gastroenterologist perspective

Lerner A.

Nutr Rev. 2022 Jan 10;80(2):282-293. doi: 10.1093/nutrit/nuab024.

Arachidonic Acid Metabolites in Neurologic Disorders

Kursun O, Karatas H, Bariskaner H, Ozturk S.

CNS Neurol Disord Drug Targets. 2022;21(2):150-159. doi: 10.2174/1871527320666210512013648.

Flavonoids, the Family of Plant-Derived Antioxidants Making Inroads into Novel Therapeutic Design Against Ionizing Radiation-Induced Oxidative Stress in Parkinson's Disease

Behl T, Kaur G, Sehgal A, Zengin G, Singh S, Ahmadi A, Bungau S.

Curr Neuropharmacol. 2022;20(2):324-343. doi: 10.2174/1570159X19666210524152817.

Subacute Cerebral Infarction With Accumulation of 99mTc-TRODAT in the Parkinson Disease Patient

Kao CH, Chiu CH.

Clin Nucl Med. 2022 Jan 1;47(1):68-69. doi: 10.1097/RLU.0000000000003725.

Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint

Schnitzler A, Mir P, Brodsky MA, Verhagen L, Groppa S, Alvarez R, Evans A, Blazquez M, Nagel S, Pilitsis JG, Pötter-Nerger M, Tse W, Almeida L, Tomycz N, Jimenez-Shahed J, Libionka W, Carrillo F, Hartmann CJ, Groiss SJ, Glaser M, Defresne F, Karst E, Cheeran B, Vesper J; PROGRESS Study Investigators.

Neuromodulation. 2022 Aug;25(6):817-828. doi: 10.1111/ner.13407. Epub 2022 Feb 2.

Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review

Chen WN, Shaikh MF, Bhuvanendran S, Date A, Ansari MT, Radhakrishnan AK, Othman I.

Curr Neuropharmacol. 2022;20(4):799-808. doi: 10.2174/1570159X19666210528155801.

Recent Advancements and Patents on Buccal Drug Delivery Systems: A Comprehensive Review

Srivastava N, Aslam S.

Recent Pat Nanotechnol. 2022;16(4):308-325. doi: 10.2174/1872210515666210609145144.

Dapsone, More than an Effective Neuro and Cytoprotective Drug

Diaz-Ruiz A, Nader-Kawachi J, Calderón-Estrella F, Mata-Bermudez A, Alvarez-Mejia L, Ríos C.

Curr Neuropharmacol. 2022;20(1):194-210. doi: 10.2174/1570159X19666210617143108.

A Review on Chitosan in Drug Delivery for Treatment of Neurological and Psychiatric Disorders

Shayganfard M.

Curr Pharm Biotechnol. 2022;23(4):538-551. doi: 10.2174/1389201022666210622111028.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias